Esophagogastric Adenocarcinoma
11 clinical trials · Condition
◉ Watch Esophagogastric Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Molecular Characteristics of Gastroesophageal Adenocarcinoma (MOCHA): A Prospective Feasibility Study (NCT04219137) | University Health Network, Toronto | 2019-11-14 |
| Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma (NCT03921021) | Weill Medical College of Cornell University | 2019-05-09 |
| Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric Adenocarcinoma (NCT03193918) | Arog Pharmaceuticals, Inc. | 2017-04-14 |
| Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN) (NCT02856867) | European Organisation for Research and Treatment of Cancer - EORTC | 2016-12-01 |
| Nintedanib in Patients With Advanced Esophagogastric Cancer (NCT02234596) | Memorial Sloan Kettering Cancer Center | 2014-09-04 |
Track Esophagogastric Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.